Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): regulators of proteolysis during cancer invasion and prognostic parameters in breast cancer.
Brünner
N
N
Finsen Laboratory, Copenhagen ø, Denmark.
Pyke
C
C
Hansen
C H
CH
Rømer
J
J
Grøndahl-Hansen
J
J
Danø
K
K
D001943:Breast Neoplasms / Q000201:enzymology / Q000473:pathology / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008666:Metalloendopeptidases / Q000502:physiology*; D009361:Neoplasm Invasiveness; D017395:Plasminogen Activator Inhibitor 1 / Q000502:physiology*; D011379:Prognosis; D012697:Serine Endopeptidases / Q000502:physiology*; D014568:Urokinase-Type Plasminogen Activator / Q000037:antagonists & inhibitors / Q000502:physiology*
D017395:Plasminogen Activator Inhibitor 1; D012697:Serine Endopeptidases; D014568:Urokinase-Type Plasminogen Activator; D008666:Metalloendopeptidases